SSA
ATYR

Schonfeld Strategic Advisors’s aTyr Pharma ATYR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,264
Closed -$392K – 2650
2025
Q2 		$392K Sell
77,264
-25,442
-25% -$100K ﹤0.01% 1615
2025
Q1 		$310K Buy
102,706
+39,071
+61% +$142K ﹤0.01% 1770
2024
Q4 		$230K Sell
63,635
-322,949
-84% -$978K ﹤0.01% 1717
2024
Q3 		$680K Buy
386,584
+347,684
+894% +$633K ﹤0.01% 1305
2024
Q2 		$60.7K Buy
38,900
+18,400
+90% +$32K ﹤0.01% 1915
2024
Q1 		$40K Buy
+20,500
New +$35.8K ﹤0.01% 1906
2023
Q3 		– Sell
-11,100
Closed -$24K – 2387
2023
Q2 		$24K Buy
+11,100
New +$24.2K ﹤0.01% 1884

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's ATYR Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of aTyr Pharma (ATYR) in Q3 2025, closing a stake of 77,264 shares — an estimated $392K sold.

Schonfeld Strategic Advisors first reported a position in ATYR in Q2 2023 and held it in 7 quarters. The position peaked at $680K in Q3 2024. 103 funds tracked by Wall St. Rank hold ATYR as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining aTyr Pharma position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 77,264 aTyr Pharma shares in Q3 2025, an estimated $392K.
  • Schonfeld Strategic Advisors first reported a position in aTyr Pharma in Q2 2023 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's aTyr Pharma position peaked at $680K in Q3 2024.
  • 103 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.